Patient Resources & Guides
Below are some trusted institutions and relevant websites for frequently asked urological questions. You’ll find links and general information about common kidney, prostate, and bladder conditions here.
Cancer Council Victoria
The Cancer Council Victoria has developed an international reputation for innovative work in cancer research, prevention and support. Their website provides an excellent overview of all cancers, including urological cancers.
Prostate Cancer Foundation of Australia
A broad-based community organisation and peak national body for prostate cancer in Australia involved in research, awareness and support programs.
Kidney Health Australia
The Peak Body for Kidney Health in Australia provides trustworthy and up-to-date resources and support to help people manage kidney diseases, such as cancer, stones, urinary tract infections, and kidney disease.
Continence Foundation of Australia
Providing information for men and women about the different types of incontinence and various treatments available to improve control.
British Association of Urological Surgeons
The British Association of Urological Surgeons website explains in detail many urological procedures.
Clinical References
HOLEP:
- Benzouak, T., et al. (2025). "Assessing the Risk of Urinary Tract Infections and Urosepsis after HoLEP: An Event-Rate Meta-Analysis." The Journal of Urology. A highly recent meta-analysis of over 20,000 patients reinforcing HoLEP's standing as a highly effective and safe treatment modality with an exceptionally low risk of post-operative infectious complications. (Link: https://www.auajournals.org/doi/10.1097/01.JU.0001110064.72214.9d.29)
- Maheshwari, P. N., et al. (2023). "TURP vs HoLEP for Large Benign Prostatic Adenoma: Comparison of Perioperative Outcomes and PSA Dynamics." The Journal of Urology. This recent prospective trial confirms that HoLEP provides superior symptomatic improvement and a more complete adenoma resection (based on PSA dynamics) compared to traditional TURP. (Link: https://www.auajournals.org/doi/10.1097/01.JU.0001110064.72214.9d.26)
- Han, T., et al. (2020). "Holmium Laser Enucleation of the Prostate as a Size-Independent Treatment in Large Prostates >150 Grams." The Journal of Urology. This contemporary clinical review validates HoLEP as a durable, effective, and size-independent treatment, successfully managing even massively enlarged prostates with excellent functional outcomes. (Link: https://www.auajournals.org/doi/10.1097/JU.0000000000000978.08)
- Yin, L., et al. (2013/2019 updates). "Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials." The Journal of Urology. A foundational meta-analysis demonstrating that HoLEP results in less perioperative morbidity, shorter hospitalisation, and superior urodynamic outcomes compared to TURP. (Link: https://www.auajournals.org/journal/juro)
- Elzayat, E. A., et al. (2007). "Holmium Laser Enucleation of the Prostate (HoLEP): Long-Term Results, Reoperation Rate, and Possible Impact of the Learning Curve." European Urology. A landmark long-term study that definitively established HoLEP as the size-independent gold standard, noting highly durable outcomes and an exceptionally low reoperation rate. (Link: https://europeanurology.com/article/S0302-2838(07)00035-7/fulltext)
- Wilson, L. C., Gilling, P. J., et al. (2006). "A Randomised Trial Comparing Holmium Laser Enucleation Versus Transurethral Resection in the Treatment of Prostates Larger Than 40 Grams: Results at 2 Years." European Urology. A pivotal randomised trial from the pioneers of the procedure, demonstrating the distinct advantages of HoLEP over TURP regarding safety and surgical efficiency. (Link: https://europeanurology.com/article/S0302-2838(06)00650-5/fulltext)
Rezum:
- McVary, K. T., et al. (2021). "Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia." The Journal of Urology. This provides the highest level of level-one evidence confirming the 5-year durability, safety, and strict preservation of sexual function with Rezum therapy. (Link:
https://www.auajournals.org/doi/10.1097/JU.0000000000001778)
- Kang, T., et al. (2020). "Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia." Cochrane Database of Systematic Reviews. A comprehensive systematic review confirming the rapid onset of symptom relief and reliable outcomes of Rezum as a minimally invasive outpatient procedure. (Link: https://pubmed.ncbi.nlm.nih.gov/32219851/)
Robotic surgery:
- Benzouak, T., et al. (2025). "Comparative Analysis of Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy in Benign Prostatic Hyperplasia Management: A Systematic Review and Meta-Analysis." The Journal of Urology. A highly relevant and recent meta-analysis from a top-tier journal directly comparing robotic simple prostatectomy with HoLEP, validating the robust functional outcomes of robotic approaches for significantly enlarged glands. (Link: https://www.auajournals.org/doi/10.1097/JU.0000000000004297)
- Nemer, P. F., et al. (2024). "A Comparison Between Robotic Simple Prostatectomy and Endoscopic Enucleation of the Prostate for Management of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis." The Journal of Urology. This meta-analysis assesses functional outcomes and establishes the robust evidence base for robotic simple prostatectomy in managing significantly enlarged glands. (Link: https://www.auajournals.org/doi/abs/10.1097/01.JU.0001008732.80104.31.04)





